SL No | Subtypes | Recommendations by -ACS, IASLC. | Non-surgical options -A | Surgical Options -B |
---|---|---|---|---|
1. | Ground glass nodules | Defer surgery | Defer surgery | |
Pulmonary metastases | ||||
2 | Carcinoids | Defer surgery | Defer surgery | |
3 | Mediastinal tumors- Thymoma | Defer surgery unless symptomatic | Defer surgery | |
4 | NSCLC | Defer surgery |
Defer surgery In adenocarcinoma- consider oral targeted therapy if suggested by mutational analysis |
Defer surgery |
T1a/T1b and node negative | ||||
5 | NSCLC | Consider early surgery for operable tumors |
Neoadjuvant chemotherapy In adenocarcinoma- consider oral targeted therapy if suggested by mutational analysis |
Defer surgery until progression |
T1c or above and cN0, cN1 | ||||
6 | Emergency indication- Bleeding/hemoptysis, obstructed airway | Consider non-invasive intervention procedures, if fails surgery | Consider non-invasive intervention procedures, if fails surgery |